Adenosine and ATP receptors.
Adenosine and ATP, via P1 and P2 receptors respectively, can modulate pain transmission under physiological, inflammatory, and neuropathic pain conditions. Such influences reflect peripheral and central actions and effects on neurons as well as other cell types. In general, adenosine A1 receptors produce inhibitory effects on pain in a number of preclinical models and are a focus of attention. In humans, i.v. infusions of adenosine reduce some aspects of neuropathic pain and can reduce postoperative pain. For P2X receptors, there is a significant body of information indicating that inhibition of P2X3 receptors may be useful for relieving inflammatory and neuropathic pain. More recently, data have begun to emerge implicating P2X4, P2X7 and P2Y receptors in aspects of pain transmission. Both P1 and P2 receptors may represent novel targets for pain relief.
Sawynok
J
J
Department of Pharmacology, Dalhousie University, Halifax NS, B3H 1X5, Canada. jana.sawynok@dal.ca
D000241:Adenosine / Q000008:administration & dosage / Q000627:therapeutic use; D000700:Analgesics / Q000494:pharmacology*; D000818:Animals; D006801:Humans; D010146:Pain / Q000188:drug therapy* / Q000503:physiopathology*; D018047:Receptors, Purinergic P1 / Q000187:drug effects*; D018048:Receptors, Purinergic P2 / Q000187:drug effects*
D000700:Analgesics; D018047:Receptors, Purinergic P1; D018048:Receptors, Purinergic P2; D000241:Adenosine